Delivery Order SPE2DR25D1053-SPE2DR26FT382
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Sensorcaine-MPF 0.5% in 30 mL vials, with a ceiling value of $2,111.04 and an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $3,629.70 delivery order to AmerisourceBergen Drug Corp on July 27, 2025, for the supply of Sensorcaine-MPF 0.5% vials (30 mL). The contract, which is not set-aside and employs firm fixed pricing, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. Performance is scheduled for completion by July 28, 2025, with work to be performed at the contractor's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a $10,447.93 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 20, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,699.83 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 1, 2025. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,931.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE: 0U9U0) on May 21, 2025, with an ultimate completion date of May 22, 2025. This is a non-set-aside, competitively awarded contract with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,244.42 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $14,800.80 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,933.40 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 1, 2025, with an ultimate completion date of November 3, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. The award was competitively...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,063.72 to AmerisourceBergen Drug Corp on September 25, 2025, for pharmaceutical and medical supply products. This is an unset-aside, competitively awarded contract with firm fixed pricing, with ultimate completion scheduled for September 26, 2025. The order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT382Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,179.83 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Sensorcaine-MPF 0.5% in 30 mL vials. This is a firm fixed-price contract with an ultimate completion date of October 29, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded through open competition. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. Sensorcaine-MPF is a local anesthetic used in clinical and surgical settings, reflecting the company's role in providing specialized pharmaceutical commodities across multiple therapeutic domains. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible DLA prime vendor vehicle, which enables pharmaceutical support for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/28/25 |